Prosecution Insights
Last updated: October 28, 2026
Application No. 17/946,913

WEARABLE MEDICAL DEVICE SYSTEM WITH CAREGIVER NOTIFICATIONS

Non-Final OA §101
Filed
Sep 16, 2022
Examiner
HUSSAINI, ATTIYA SAYYADA
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
West Affum Holdings Dac
OA Round
5 (Non-Final)
62%
Grant Probability
Moderate
5-6
OA Rounds
0m
Est. Remaining
81%
With Interview

Examiner Intelligence

Grants 62% of resolved cases
62%
Career Allowance Rate
29 granted / 47 resolved
-8.3% vs TC avg
Strong +20% interview lift
Without
With
+19.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
26 currently pending
Career history
93
Total Applications
across all art units

Statute-Specific Performance

§101
4.6%
-35.4% vs TC avg
§103
50.8%
+10.8% vs TC avg
§102
21.0%
-19.0% vs TC avg
§112
21.9%
-18.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 47 resolved cases

Office Action

§101
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 28 April 2026 has been entered. Response to Amendment This Office Action is responsive to the RCE comprising the amendments from the after final amendment filed 13 April 2026. As per the amendment: claim 22 has been amended and no claims have been added or cancelled. Thus claims, 22-23, 26-27, 29-37, and 39-44 are presently pending and under examination. Response to Arguments Response to Arguments Regarding 35 USC 103 Applicant’s arguments, see pg. 6-9 of After Final Amendment, filed 13 April 2026, with respect to 35 USC 103 rejection of independent claim 22 have been fully considered and are persuasive. Therefore, the rejection of claims 22-23, 26-27, 29-37, and 39-44 has been withdrawn. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 22-23, 26-27, 29-37, and 39-44 rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. Step 1: Claim 22 is directed to a method of providing care to a patient wearing a wearable cardioverter defibrillator (WCD), which is within the four statutory categories. Step 2A, Prong One: Claim 22 recites the limitations of: A method of providing care to a patient wearing a wearable cardioverter defibrillator (WCD), the method comprising: receiving, by a patient communication device, patient data from a communication module of the WCD, the patient data corresponding to one or more signals sensed by the WCD; transmitting the patient data from the patient communication device to a remote monitoring system; determining, by the patient communication device, that the patient data meets one or more predetermined notification criteria;and responsive to determining by the patient communication device that the patient data meets the one or more predetermined notification criteria, selecting, by the patient communication device, a notification from a notifications library stored in the patient communication device based on the one or more predetermined notification criteria, and transmitting, by the patient communication device, the selected notification to a designated caregiver communication device, wherein the designated caregiver communication device determines a type of situation associated with the patient and a location of the patient communication device from the notification, and wherein the designated caregiver communication device determines one or more instructions using a database that stores default instruction options, based on the type of situation determined from the notification, the one or more instructions comprising at least one of instructions to check one or more of vital signs and to administer CPR for the patient. (emphasis added) These above limitations, under their broadest reasonable interpretation, are directed to mental processes, mathematical operations, and certain methods of organizing human activity because they recite managing personal behavior or relationships or interactions between people (i.e. social activities, teachings, and following rules or instructions – in this case the displaying patient information and instructions to a caregiver based on the information meeting a criteria). Step 2A, Prong Two: Claim 22 only recites the additional limitations of “a wearable cardioverter defibrillator (WCD)”, “patient communication device”, “remote monitoring system”, “communication module”, and “designated caregiver communication device”. These additional elements are recited at a high-level of generality (i.e. most generic computer and medical communication systems would be known to have these components for general computations, processing, transmitting, communication, and outputting sensed data), and they amount to no more than mere applying the abstract idea by the use of a general-purpose computer. The claims further includes the limitations of “check one or more of vital signs” and “administer CPR for the patient” is not defining a “particular treatment” as required to be considered a practical application. According to MPEP 2106.04(d)(2), “The treatment or prophylaxis limitation must be “particular,” i.e., specifically identified so that it does not encompass all applications of the judicial exception(s).” These elements do not amount to significantly more as they are merely extra-solution activity to display instructions. Step 2B: The claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception. As discussed above with respect to the integration of the judicial exception into a practical application (Step 2A – Prong Two), the limitations are merely implementing the abstract idea on general-purpose computer and medical communication systems to carry out the process electronically instead of by hand. Dependent claims 23, 26-27, 29-37 and 44 merely describe the type of information, instruction, or notification that is displayed (i.e. nonfunctional descriptive material). Dependent claims 39-43 include additional elements that merely provide extra-solution activity of transmitting and displaying information. Therefore, claims 22-23, 26-27, 29-37, and 39-44 are rejected under 35 USC 101 because the claimed invention is directed to an abstract idea without significantly more. Allowable Subject Matter Claims 22-23, 26-27, 29-37, and 39-44 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 101, set forth in this Office Action. The following is a statement of reasons for the indication of allowable subject matter: The instant invention in claim 22 is directed to a method for providing care to a patient wearing a wearable cardioverter defibrillator (WCD). Applicant’s arguments, see pg. 6-9 of After Final Amendment Remarks, filed 13 April 2026, with respect to 35 USC rejections of independent claim 22 under Seese et al. (WO 2023/150749 A1) in view of Medema et al. (EP 3357534 B1) in view of Stadler et al. (US 2022/0280047 A1) have been fully considered and are persuasive. Therefore, the rejection of independent claim 22 has been withdrawn and determined to be allowable over the prior art. Additionally, the Examiner also agrees with the arguments that the applied references, alone or in any proper combination, do not disclose or suggest the subject matter recited by Applicant’s claims and there would have been no apparent reason that would have caused one of ordinary skill in the art to modify the systems and the processes by the applied references to arrive at the claimed subject matter, specifically the limitation of: selecting, by the patient communication device, a notification from a notifications library stored in the patient communication device based on the one or more predetermined notification criteria (emphasis added). Claims 23, 26-27, 29-37, and 39-44 depend from and thus further limit claim 1, and therefore are also allowed. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to ATTIYA SAYYADA HUSSAINI whose telephone number is (703)756-5921. The examiner can normally be reached Monday-Friday 8:00 am - 5:00 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Niketa Patel can be reached at 5712724156. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ATTIYA SAYYADA HUSSAINI/Examiner, Art Unit 3792 /NIKETA PATEL/Supervisory Patent Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Show 6 earlier events
Jul 31, 2025
Response after Non-Final Action
Aug 25, 2025
Non-Final Rejection mailed — §101
Nov 25, 2025
Response Filed
Feb 13, 2026
Final Rejection mailed — §101
Apr 13, 2026
Response after Non-Final Action
Apr 28, 2026
Request for Continued Examination
Apr 30, 2026
Response after Non-Final Action
Sep 30, 2026
Non-Final Rejection mailed — §101 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12758778
LOCAL FIELD POTENTIAL (LFP) SENSING FOR NEUROSTIMULATION CONTROL
3y 1m to grant Granted Oct 13, 2026
Patent 12752115
NEUROMODULATION FOR TREATMENT OF NEONATAL CHRONIC HYPERINSULINISM
3y 6m to grant Granted Oct 06, 2026
Patent 12746372
BALLOON CATHETER
4y 0m to grant Granted Sep 29, 2026
Patent 12728038
CORNEAL LENTICULAR INCISION USING A FEMTOSECOND LASER WITH IMPROVED SCANLINE SWEEP SPEED PROFILE
2y 6m to grant Granted Sep 08, 2026
Patent 12721567
SYSTEMS AND METHODS FOR DETECTING REM BEHAVIOR DISORDER
3y 11m to grant Granted Sep 01, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
62%
Grant Probability
81%
With Interview (+19.5%)
3y 3m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 47 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month